422 related articles for article (PubMed ID: 2817813)
41. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
42. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
43. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
Losinno C; Wines BD; Johns TG; Mackay IR
Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
[TBL] [Abstract][Full Text] [Related]
44. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
45. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
Lanier LL; Benike CJ; Phillips JH; Engleman EG
J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
[TBL] [Abstract][Full Text] [Related]
46. Differential effects of interferon-alpha 2 and interleukin-2 on natural killer cell activity in patients with acquired immune deficiency syndrome.
Reddy MM; Chinoy P; Grieco MH
J Biol Response Mod; 1984 Aug; 3(4):379-86. PubMed ID: 6332880
[TBL] [Abstract][Full Text] [Related]
47. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
48. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity.
D'Orazio JA; Burke GW; Stein-Streilein J
J Immunol; 1995 Feb; 154(3):1014-23. PubMed ID: 7529788
[TBL] [Abstract][Full Text] [Related]
49. The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins.
Gustafsson A; Sundström S; Lundgren E
J Immunol; 1986 Jul; 137(1):167-71. PubMed ID: 3086447
[TBL] [Abstract][Full Text] [Related]
50. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
51. Changes in gene expression associated with IFN-beta and IL-2-induced augmentation of human natural killer cell function.
Kornbluth J; Hoover RG
J Immunol; 1988 Nov; 141(9):3234-40. PubMed ID: 3049820
[TBL] [Abstract][Full Text] [Related]
52. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
Sharma B; Vaziri ND
Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
[TBL] [Abstract][Full Text] [Related]
53. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
Bukowski JF; Biron CA; Welsh RM
J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.
Harris DT; Cianciolo GJ; Snyderman R; Argov S; Koren HS
J Immunol; 1987 Feb; 138(3):889-94. PubMed ID: 2433333
[TBL] [Abstract][Full Text] [Related]
55. Rapid induction of seven proteins in human lymphocytes by interferon; correlation to natural killer cell activity.
Gustafsson A; Sundström S; Ny T; Lundgren E
J Immunol; 1982 Nov; 129(5):1952-9. PubMed ID: 6181151
[TBL] [Abstract][Full Text] [Related]
56. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients.
Koren HS; Brandt CP; Tso CY; Laszlo J
J Biol Response Mod; 1983; 2(2):151-65. PubMed ID: 6644332
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicity.
Gersuk GM; Chang WC; Pattengale PK
J Immunol; 1988 Dec; 141(11):4031-8. PubMed ID: 2846698
[TBL] [Abstract][Full Text] [Related]
58. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
59. Systemic alkalinization inhibits the ability of flavone acetic acid to augment natural killer activity, induce cytokine gene expression, and synergize with interleukin 2 for the treatment of murine renal cancer.
Futami H; Hornung RL; Back TT; Bull R; Gruys E; Wiltrout RH
Cancer Res; 1990 Dec; 50(24):7926-31. PubMed ID: 2253233
[TBL] [Abstract][Full Text] [Related]
60. Studies on the natural killer cell activity of human nonadherent mononuclear cells (nMNC) with tumor necrosis factor, interleukin-1, interferon-gamma and cisplatin.
Pai K; Sodhi A
Neoplasma; 1992; 39(6):363-7. PubMed ID: 1491726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]